KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells

Krishnan K. Mahadevan(The University of Texas MD Anderson Cancer Center), Kathleen M. McAndrews(The University of Texas MD Anderson Cancer Center), Valerie S. LeBleu(Northwestern University), Sujuan Yang(The University of Texas MD Anderson Cancer Center), Hengyu Lyu(The University of Texas MD Anderson Cancer Center), Bingrui Li(The University of Texas MD Anderson Cancer Center), Amari M. Sockwell(The University of Texas MD Anderson Cancer Center), Michelle L. Kirtley(The University of Texas MD Anderson Cancer Center), Sami J. Morse(The University of Texas MD Anderson Cancer Center), Barbara A. Moreno Diaz(The University of Texas MD Anderson Cancer Center), Michael P. Kim(The University of Texas MD Anderson Cancer Center), Ningping Feng(The University of Texas MD Anderson Cancer Center), Anastasia M. Lopez(The University of Texas MD Anderson Cancer Center), Paola A. Guerrero(The University of Texas MD Anderson Cancer Center), Francesca Paradiso(The University of Texas MD Anderson Cancer Center), Hikaru Sugimoto(The University of Texas MD Anderson Cancer Center), Kent A. Arian(The University of Texas MD Anderson Cancer Center), Haoqiang Ying(The University of Texas MD Anderson Cancer Center), Yasaman Barekatain(The University of Texas MD Anderson Cancer Center), Lakshmi Kavitha Sthanam(The University of Texas MD Anderson Cancer Center), Patience J. Kelly(The University of Texas MD Anderson Cancer Center), Anirban Maitra(The University of Texas MD Anderson Cancer Center), Timothy P. Heffernan(The University of Texas MD Anderson Cancer Center), Raghu Kalluri(The University of Texas MD Anderson Cancer Center)
Cancer Cell
August 24, 2023
Cited by 221Open Access
Full Text

Abstract


Related Papers